Trusted Drug & Disease Information at Your Fingertips

Third Party Manufacturing in Pharma: All You Need To Know

Pharmaceutical third-party manufacturing, also known as contract manufacturing, is a process where a company hires an external manufacturer to produce its pharmaceutical products under its own brand name. This arrangement allows pharmaceutical companies to focus on core activities like research, development, branding, and marketing, while the third-party manufacturer handles production, packaging, and sometimes even logistics. It is a common strategy to leverage specialized expertise, reduce capital investment, and achieve cost savings. 

What is a third-party manufacturing pharma company?

A third-party manufacturing pharma company, or contract manufacturing organization (CMO), is the external manufacturer that produces drugs for other pharmaceutical companies. They focus on the production aspect of the supply chain and often have the necessary facilities, certifications, and expertise

How it works :

  • Agreement: A contract is signed between the pharmaceutical company and the third-party manufacturer, outlining product specifications, quality standards, and delivery timelines.
  • Sourcing and production: The third-party manufacturer sources the raw materials and handles the entire production process according to the agreed-upon specifications and quality standards.
  • Packaging and branding: The final products are packaged and labeled with the contracting company’s brand name
  • Distribution: The manufacturer may handle the delivery of the finished goods to the contracting company, which then manages its own distribution and sales. 

Key benefits

  • Focus on core competencies: Companies can concentrate on research, development, and marketing without the overhead of managing a manufacturing facility.
  • Cost savings: It avoids the high capital investment required to build and maintain manufacturing plants.
  • Faster time to market: Outsourcing can accelerate the speed at which new products are brought to market.
  • Access to expertise and technology: Companies gain access to specialized manufacturing capabilities and advanced technologies that they might not possess in-house.
  • Flexibility and scalability: The model allows for flexible production volumes that can be adjusted to meet market demand without being limited by fixed production capacities. 

Key pharma segments for third-party manufacturing

  • Tablets and capsules

  • Syrups and suspensions

  • Dry powder injections

  • Liquid injections

  • Ointments and topical creams

  • Nutraceuticals and dietary supplements

  • Protein powders 

  • Herbal and ayurvedic products

  • Topical lotions

  • Eye & ear drops

  • Medicated soaps

  • Nasal sprays

  • Medicated lozenges

  • Respiratory solutions (Repules)

  • Inhalers 

  • IV fluids

  • Soft gelatin capsule

  • Surgical Items 

  • Gummy candies

  • Energy drinks

  • Latex products (Condoms, gloves etc.)

  • Sachets (ORS, pre & probiotics etc)

  • Medicated shampoo

  • Veterinary / Animal health products

  • Topical gel

  • Topical spray

  • Topical oil

  • Multivitamin Malt

  • Pediatric drops

  • Mouth wash

  • Medicated toothpaste

  • Hair oil

Scroll to Top